The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors.
To date, most experiments examining the myelination potential of transplanted cells have been undertaken into either the immature nervous system or into acutely demyelinating lesions. Since these are situations where myelination or remyelination are occurring, such studies provide little information on the likely outcome of introducing myelinogenic cells into area of chronic demyelination. In an attempt to gain a greater understanding of the interaction between astrocytes and oligodendrocyte progenitors in areas of demyelination, we undertook transplantation experiments in which an identical preparation of oligodendrocyte progenitors (OPCs) was (1) transplanted directly into astrocyte-free areas of acute demyelination (3 days after induction), (2) transplanted cranial to similar areas of demyelination (20 days after induction) or (3) transplanted cranial to areas of demyelination (20 days after induction) that had been injected with astrocytes at 3 days to confront OPCs with demyelinated axons in an astrocytic environment. The acute astrocyte-free lesions were remyelinated by oligodendrocytes and Schwann cells while the delayed interaction of OPCs with demyelinating lesions resulted in only oligodendrocyte remyelination, the extent of which was reduced when the area of demyelination contained astrocytes. The results of these experiments illustrate that the introduction of OPCs into an astrocyte-free area of demyelination soon after its induction favours Schwann cell differentiation while the presence of established astrocytes in an area of demyelination has an inhibitory effect on the extent of oligodendrocyte remyelination achieved by OPCs.
Blakemore
William F
WF
Department of Clinical Veterinary Medicine, University of Cambridge, Cambridge CB3 OES, UK. wfb1000@cam.ac.uk
Gilson
Jennifer M
JM
Crang
A John
AJ
D000818:Animals; D001253:Astrocytes / Q000166:cytology* / Q000502:physiology; D016380:Brain Tissue Transplantation; D002454:Cell Differentiation; D003711:Demyelinating Diseases / Q000139:chemically induced / Q000503:physiopathology*; D004791:Enzyme Inhibitors / Q000633:toxicity; D004996:Ethidium / Q000633:toxicity; D005260:Female; D009836:Oligodendroglia / Q000166:cytology / Q000637:transplantation*; D051381:Rats; D012583:Schwann Cells / Q000166:cytology / Q000502:physiology; D013118:Spinal Cord Diseases / Q000601:surgery*; D033581:Stem Cell Transplantation; D013997:Time Factors
D004791:Enzyme Inhibitors; D004996:Ethidium